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Abstract
Background: Exposure to continuous and impulse noise can induce a hearing loss. Leupeptin is an inhibitor of the
calpains, a family of calcium-activated proteases which promote cell death. The objective of this study is to assess
whether Leupeptin could reduce the hearing loss resulting from rifle impulse noise.
Methods: A polyethelene tube was implanted into middle ear cavities of eight fat sand rats (16 ears). Following
determination of auditory nerve brainstem evoked response (ABR) threshold in each ear, the animals were exposed
to the noise of 10 M16 rifle shots. Immediately after the exposure, saline was then applied to one (control) ear and
non-toxic concentrations of leupeptin determined in the first phase of the study were applied to the other ear, for
four consecutive days.
Results: Eight days after the exposure, the threshold shift (ABR) in the control ears was significantly greater (44 dB)
than in the leupeptin ears (27 dB).
Conclusion: Leupeptin applied to the middle ear cavity can reduce the hearing loss resulting from exposure to
impulse noise.
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Background
Exposure to continuous noise can induce a hearing loss
(noise induced hearing loss = NIHL) which can be tem-
porary (TTS) or permanent (PTS), depending on the
intensity of the noise and its duration. Studies with
drugs designed to alleviate this hearing loss (HL) have
s h o w nt h a tt h em a j o rm e c h a n i s mi n v o l v e di ni n d u c i n g
this HL is related to the generation in the ear of exces-
sive levels of free radicals which lead to the breakdown
of essential molecules and structures in the inner ear
[1,2]. The high levels of free radicals are produced as a
byproduct of the elevated metabolism which is needed
to maintain the electro-chemical gradients required by
the cochlear amplifier in order to induce active displace-
ments of the outer hair cells and the basilar membrane
in the cochlea during the noise exposure [3]. Therefore
drugs which decrease the active displacements such as
salicylic acid [4] and furosemide [1], or anti-oxidants for
example N acetyl-L-cysteine (NAC) [5,6] and vitamins
A, C, E [7], which counteract free radicals, have been
shown to be effective in reducing the resultant HL.
These drugs have been shown to provide maximal pro-
tection from the noise if they are administered just
before the continuous noise exposure (salicylic acid and
furosemide) or when their injection begins just before
and continues after the exposure (NAC, vitamins).
The present study evaluated the NIHL resulting from
exposure to impulse noise and the ability of a drug with
a different mechanism of action than the aforementioned
drugs to alleviate the resulting HL. In contrast to contin-
uous noise, impulse noise is intermittent. In addition to
an intense noise level (which may also lead to synthesis
of excessive free radicals, as with continuous noise),
impulse noise includes a component of rapid rise in the
intensity of the sound pressure, which can cause direct
mechanical damage (tearing) to inner ear structures [8,9].
An example of impulse noise is that produced by the fir-
ing of an M16 rifle, which reaches peak levels of about
165 dB SPL with a rise time of 88 μsec [10]. * Correspondence: haim.ga@012.net.il
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the HL resulting from exposure to the impulse noise of
an M16 rifle was leupeptin. This drug is an inhibitor of
the calpains, a family of calcium-activated proteases
which promote cell death as a result of the breakdown
of membranes, proteins and transcription factors. The
roles of the protease calpain and that of leupeptin have
been reviewed [11]. Previous studies have led to the sug-
gestion that calpain may also be involved in NIHL. For
example, Haupt and Scheibe [12] reported that in gui-
nea pigs exposed to loud broadband noise, the partial
pressure of oxygen in the perilymph and the cochlear
blood flow were reduced. This may promote calpain up-
regulation in early stages of apoptotsis within the organ
of Corti. In addition, infusion of leupeptin into scala
tympani led to a reduction in the hearing loss (assessed
with the auditory evoked response) resulting from a 14
day exposure of chinchillas to a 100 dB SPL octave
band noise centered at 4.0 kHz [13].
It has been reported that leupeptin applied to organ
cultures from the cochlea, from utricular maculae and
from the crista of the semicircular canals, was able to
reduce the hair cell loss resulting from addition of gen-
tamicin to the organ cultures [14]. Furthermore, when
the drug was infused into the inner ear, it led to a
reduction in the amount of hair cell loss following expo-
sure to noise [15]. Since cell death (outer hair cells) fol-
lowing noise exposure occurs at a later stage in the
development of HL, it was thought that leupeptin may
possibly rescue the sensory epithelium in the cochlea.
Accordingly, experimental animals were exposed to
M16 rifle shots and then a non-toxic concentration of
leupeptin was applied to one middle ear and saline to
the opposite ear. Several days later, the threshold shift
in the leupeptin ear was smaller than that in the saline
(control) ear.
Materials and methods
All experimental procedures were authorized by the
Hebrew University- Hadassah Medical School Animal
Care and Use Committee.
The present study consisted of two phases.
General description for both phases
The first phase was a functional assessment of hearing
following application of various concentrations of leu-
peptin to the middle ear cavity in order to assess possi-
ble ototoxicity and to determine the non-toxic
concentration of the drug to be applied to the ear in
the second phase of the study. The second phase was
to investigate the potential neuroprotective effect of
non-toxic concentrations of leupeptin introduced to
the middle ear cavity after exposure to traumatic
impulse noise.
The overall study was conducted on a total of 20 adult
fat sand rats (Psammomys obesus) with a mean body
weight of 219 g (200 g to 260 g). The fat sand rat is a
rodent species found in the deserts of the Middle East
and northern Africa. The frequency range of highest
auditory sensitivity in this species is between 0.5 to 5
kHz [16], lower than that in other rodents, and similar
to that of humans. It was chosen for the present study
because of its unique middle and inner ear anatomy
consisting of a large bulla cavity, a thin otic capsule, and
an inner ear that clearly projects into the middle ear
cavity [17]. This anatomy allows delicate middle and
inner ear procedures. In addition, our laboratory has
extensive experience in induction and recording of
short-latency auditory evoked potentials in this rodent,
which were used in this study for functional evaluation
of the auditory system.
Solutions of leupeptin and additional relevant drugs
were administered into the middle ear of the animals
through an implanted polyethylene tube. In order to
introduce the tube, the animals were anesthetized with
intraperitoneal injection of 25 mg/kg pentobarbital and
additional doses were given intraperitoneally as needed.
While the animals were under anesthesia, rectal tem-
perature was monitored using a thermistor probe (Yel-
low Spring Instruments, Yellow Springs, OH) and
maintained at 37°C ± 0.5°C (using heating pads).
All animals underwent bilateral introduction of the
polyethylene tube into the middle ear cavity for repeti-
tive application of a drug solution into the middle ear.
The surgical procedure included a small incision behind
the pinna of the ear, and exposure of the bone. A small
hole in the bone of the cortex was created between the
superior and inferior horizontal septa. After visualizing
the round window, a 1.5-cm length of polyethylene tube
(external diameter 1.27 mm; internal diameter 0.86 mm)
was inserted through the small hole in the bone with
one end in position opposite the round window, and the
other end of the tube was then fixed externally to the
bone with glue and to the skin with 3-0 silk suture.
Auditory function was assessed by recording the audi-
tory nerve-brainstem evoked responses (ABR) in
response to alternating polarity broadband clicks pre-
sented at a rate of 20.6 clicks per second from an inten-
sity of 120 dB peak equivalent (pe) sound pressure level
(SPL) down to threshold in 5-dB steps by an insert ear-
phone within the external ear canal of the studied ear.
The ABR was elicited and evaluated using standard clin-
ical equipment (Navigator Pro System, Biological Sys-
tems Corporation, Mundelein, Illinois, USA), with
recording subdermal needle electrodes (Grass Instru-
ment Division, Astro-Med Inc., West Warwick, RI,
USA) at the vertex referred to the chin, and a ground
electrode in the left hindlimb. The recorded activity was
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128). Threshold was defined as the lowest intensity that
elicited repeatable responses in at least three repeated
measurements.
Phase I: Methods: Determination of a non-toxic
concentration of leupeptin
This phase was conducted on 6 animals (12 ears) in
which a volume of 0.2 cc of different concentrations of
leupeptin (15% to 0.01%) dissolved in saline solution
was applied to the middle ear cavity through the poly-
ethylene tube. In several animals, a different concentra-
tion of leupeptin was applied to each ear (see table 1).
Six additional animals served as controls for this phase.
The six control animals received 0.2 cc saline solution
to the left middle ear, and 0.2 cc of 40 mg/ml gentami-
cin to the right middle ear, as a known ototoxic control
to confirm that the drugs applied to the middle ear could
penetrate the inner ear (presumably through the round
window) and affect it. All drugs (leupeptin, gentamicin,
saline) were applied once every day for five consecutive
days. ABR was again recorded in the surviving animals 3
days after the final application, i.e. 8 days after the first
administration. Subsequently, a lethal dose of pentobarbi-
tal was injected intraperitoneally. A postmortem examina-
tion of the middle ear was conducted to visually assess
the effect of substances on middle ear tissue and to con-
firm that the polyethylene tube was still in place.
Phase I: Results: Determination of a non-toxic
concentration of leupeptin
Leupeptin was applied to the middle ear through the
polyethylene tube at several concentrations (beginning
with 15%, down to 0.01%) to determine its possible sys-
temic and ototoxic effects. The ABR threshold before
application of any concentration of leupeptin (baseline)
was between 50 to 60 dB pe SPL (see table 1). After
application of leupeptin at a concentration of 15% to the
right middle ear of one animal (1% was applied to its
left ear), a right head tilt was observed. Bloody otorrhea
was detected from the second day of leupeptin applica-
tion in all ears injected with 15% leupeptin. After 5 con-
secutive applications, ABR could not be recorded in the
2 ears remaining in this group which received 15% leu-
peptin (one animal died after the third injection). In 3
ears treated with middle ear application of leupeptin at
a concentration of 1%, bloody otorrhea was detected
from the 2
nd day of leupeptin application. After a period
of 5 consecutive days of application, ABR could not be
recorded in one ear and a threshold elevation to 110 dB
SPL in the second ear was observed. After middle ear
application of leupeptin at a concentration of 0.1%,
bloody otorrhea was also detected from the 2
nd day of
leupeptin application. However, after a period of 5 con-
secutive days of once a day application of 0.1% leupep-
tin, a non-significant elevation of the ABR thresholds to
60 dB SPL in 2 ears was observed. Finally, after middle
ear application of leupeptin at a concentration of 0.01%,
no otorrhea was detected, and after a period of 5 conse-
cutive days of application, ABR was not significantly ele-
vated (it reached 60 dB SPL in 2 ears). Therefore this
concentration (0.01%) was used in the second phase of
this study.
Post mortem examination revealed normal tympanic
membrane and normal middle ear anatomy and mucosa
in all ears that received leupeptin.
Ototoxic control-Results
Saline solution (control group)
The baseline mean ABR threshold of 50 dB SPL before
saline application (baseline) did not change significantly
(56.7 dB SPL) after saline application (see table 1).
Gentamicin (ototoxic control group)
After gentamicin application, ABR waves could not be
recorded in one ear and thresholds were significantly
elevated to a mean value of 111.6 (± SD 6.2) dB SPL in
the other 5 ears.
Post mortem examination revealed normal tympanic
membrane and normal middle ear anatomy and mucosa
in all ears that received gentamicin.
Table 1 Assessment of toxicity of various concentrations of leupeptin and other agents on ABR thresholds before and
3 days after middle ear application for 5 consecutive days.
Agent Concentration No Ears ABR Threshold (dB pe SPL)* Clinical observation
Baseline After Application
Leupeptin 15% 3** 55 120 Ipsilateral head tilt, bloody otorrhea
1% 2 55 115 Bloody otorrhea
0.1% 3** 56.7 60 Bloody otorrhea
0.01% 3** 50 55
Gentamicin 4% 6 50 111.6
Saline 0.9% 6 50 56.7
* No response was calculated as 120 dB
**One animal died after 3
rd injection.
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Unsuccessful attempts had been made to elicit a perma-
nent threshold shift (PTS) in animals following their
exposure to simulated M16 rifle impulse noise obtained
from an internet sound effects site, with amplifiers and
loud speakers. The peak intensity of these simulated
M16 shots either did not reach the desired intensity of
165 dB SPL or the rise time was lower than the 88 μsec
of actual M16 shots [18]. Therefore, the noise exposure
i nt h ep r e s e n ts t u d yw a st h at of real M16 rifle shots
during target practice sessions.
The experimental group consisted of 8 animals (16
ears) in which the polyethylene tube was introduced
bilaterally into the middle ear. ABR threshold was
recorded in each ear immediately after tube insertion,
and again, 8 days after exposure to noise.
The animals were exposed to ten M-16 gunshots. The
exposure level was about 165 dB SPL. The experimenter
was equipped with ear protectors during the exposure.
An attempt to measure the intensity of the impulse
noise was made using a Bruel &Kjaer, type 2218, preci-
sion integrating sound level meter (Naerum, Denmark).
It was necessary to extend the range of the sound level
meter. A cover for the microphone was fashioned from
Mack’se a r p l u g s( M c K e o nP r o d u c t s ,I n c . ,M a d i s o n
Heights, MI) material, providing a sound attenuation of
about 20 dB.
Immediately after exposure, and once a day over the
following 3 days (a total of 4 applications to each ear for
each animal), all animals received 0.2 cc of 0.01% (in
saline) of leupeptin to the right middle ear cavity and
0.2 cc saline solution to the left middle ear, through the
polyethylene tubes. The final ABR threshold was
assessed 8 days after the impulse noise exposure. The
differences (final minus initial thresholds) between the
ABR thresholds (in the ears treated with leupeptin and
separately in those given saline) after impulse noise
exposure were analyzed statistically using a 2-tailed
paired t test. A post mortem was then conducted at the
end of the experiment, examining the status of the tube
and of the middle ear.
All experimental procedures were authorized by the
Hebrew University- Hadassah Medical School Animal
Care and Use Committee.
Phase II: Results: Protective effect of leupeptin-
The mean ABR threshold before exposure (baseline) in
the 8 ears which were to receive saline following the
M16 impulse noise exposure was 51.3 ± 7.8 dB pe SPL.
The mean ABR threshold before exposure (baseline) in
the ears to be administered leupeptin after the exposure
was 51.3 ± 3.3 dB pe SPL (table 2).
One week after exposure to M16 impulse noise with 4
consecutive days of saline solution application into the
middle ear cavity through the polyethylene tube begin-
ning immediately after the exposure, the ABR threshold
was elevated to a mean value of 95.0 ± 23.9 dB pe SPL;
i.e. a mean threshold shift of 44 dB in the saline control
ears. However, one week after exposure, following 4
consecutive days of applying 0.01% leupeptin into the
middle ear cavity through the polyethylene tube, the
ABR threshold was elevated to a mean value of 78.1 ±
21.9 dB SPL; i.e. a mean threshold shift of only 27 dB in
the ears in which a 0.01% solution of leupeptin had
been administered. The difference in the threshold shift
between the two groups (saline and leupeptin) was
found to be significant; P = 0.045 (see table 2).
Post mortem examination revealed normal tympanic
membrane and normal middle ear anatomy and mucosa
in all ears and the absence of fluid in the middle ear.
Discussion
Noise-induced trauma is one of the most common, pre-
ventable causes of sensorineural hearing loss. However,
adequate treatment is not yet available and the noise
exposure causes apoptosis in the auditory sensory
epithelium. The key proteases that actively participate in
the programmed cell death are the calpains, and leupep-
tin has been shown to be able to protect auditory hair
cells from acoustic overexposure when infused directly
into the scala tympani of animals prior to noise expo-
sure [13]. However, intracochlear infusion is not a treat-
ment modality in humans, since it involves destruction
of the inner ear, thus making it not feasible in humans.
Also the presently available form of leupeptin cannot be
administered systemically. Hence, a more practical
approach involving application of the drug to the middle
ear was used in the present study. Application of drugs
through a small perforation of the tympanic membrane
is used as a treatment option, e.g. in sudden sensory
hearing loss and Meniere disease [19-21].
In this study leupeptin was applied directly into the
middle ear by means of an implanted polyethelene tube,
one end of which reached the middle ear cavity opposite
the round window, while the other end was externally
accessible. From the middle ear cavity, the drug was
able to reach the inner ear, presumably by diffusion
through the round window, as shown by the result that
a solution of the known ototoxic drug gentamicin with
a molecular weight similar to that of leupeptin (427 to
478) applied in the same way, caused a profound HL.
The form of leupeptin administered in this study could
not have been injected systemically, only topically to the
middle ear. Even though the drug solution was applied
locally, higher concentrations had systemic toxic effects,
not only local effects to the ear. Concentrations of leu-
peptin which were not systemically or locally toxic
(0.01%) were effective in protecting the inner ear from
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was applied had a significantly smaller mean threshold
shift than that in the opposite ear (control) in the same
animal to which a saline solution was applied (27 dB
compared to 44 dB).
Leupeptin has been studied extensively in animal
models to study Calpain inhibition and its tissue protec-
tive effect [11]. No evidence of toxicity has been
observed in any of these studies at the concentration
and mode of administration used (intraperitoneal, intra-
muscular, oral). It was also not ototoxic when applied
for eight weeks to the round window [22]. In the pre-
sent study and one other [23], some evidence of toxicity
w a so b s e r v e da te x t r e m e l yh i g hd o s e sa sw e l la sw h e na
mini pump was used to administer the drug directly
into the cochlea (presumably causing a high intraco-
chlear concentration of the drug).
In this study, the solutions were applied immediately
after the noise exposure and for the following three days
(a total of four applications). The efficacy of the drug
solutions applied before the exposure was not assessed
because in such a case, a conductive HL would have
been present during the noise exposure, reducing the
effectiveness of the noise exposure. A conductive HL
was probably not present at the time of the final thresh-
old determination (three days after the last drug applica-
tion) since post-mortem examination of the middle ear
found it clear of fluid.
Leupeptin, a potent inhibitor of calpains (calcium acti-
vated proteases which promote breakdown of proteins,
several enzymes and transcription factors, culminating
in cell death) applied to the middle ear cavity leads to a
significant reduction in the threshold shift caused by
exposure to impulse noise.
In future studies, we intend to administer a form of
leupeptin which can be given systemically and then to
assess its possible systemic toxicity and ototoxicity
(overall, the systemic toxicity and ototoxicity would be
dependent on the concentration of the drug at each
delivery, the time between successive applications, the
concentration of the drug in blood and the total number
of injections), its efficacy compared to other drugs in
protecting from continuous and impulse noise and to
determine the optimal time window for administration
(either before, or at several time periods after the expo-
sure) in order to obtain a maximal degree of rescue.
Conclusion
Leupeptin applied to the middle ear cavity can reduce
the hearing loss resulting from exposure to impulse
noise.
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